Duchenne Gene Therapy Will Undergo Changes After Patient Deaths

(MedPage Today) — At the FDA’s request, delandistrogene moxeparvovec (Elevidys), the only approved gene therapy for Duchenne muscular dystrophy, will carry a black box warning for acute liver injury and acute liver failure, drugmaker Sarepta Therapeutics…